Luis A Marcos

The @sbudeptofmed is pleased to announce the promotion of Dr. Luis A. Marcos @StonyBrookID @StonyBrookMed to Professor of Medicine with Tenure in the Renaissance School of Medicine @stonybrooku bit.ly/4klfcFM

New paper in @OFIDJournal “A Prospective Cohort Longitudinal Study of Human Acute Babesiosis: Quality of Life and Severity of Symptoms Through 1-Year Follow-up” bit.ly/3KF3bO9

In this SR and MA, we found compelling evidence that antiparasitic treatment significantly reduces the risk of ECG changes, disease progression, CV death, and overall mortality in chronic #Chagas’ disease AP Treatment is effective @eClinicalMed sciencedirect.com/science/articl…

@drsusan @NewYorkACP

An ongoing Lyme cohort longitudinal study at @StonyBrookID @sbudeptofmed New York shows that ~40% of patients after a Lyme diagnosis may continue to have long term symptoms, even after appropriate antibiotic treatment.Poster presented by our 2nd year ID fellow Dr.David Keninson

Amazing poster presented by our resident Khushbu #IDWeek2024 in this new research about meat allergy associated with Amblyomma tick bites. @KaliChanNews @StonyBrookID @CharlesVorkas @sbudeptofmed @LymeAlliance

Medical education for students, residents and fellows is a priority of this research program

Great meeting with UCLA folks (Global Health and ID) during IDWeek2024. Innovative research in Emerging Tropical Diseases is coming soon….@Speit_Oriente @howdoyouflu @courtney_decan @SPEIT_oficial @KaliChanNews @etcarey2 @ferraz_md

STIs in Latin America by Dr Alexis Holguin, current head of ID Peruvian Society. 3.36M new syphilis cases in 2022 in the Americas!

News from IDWeek2024, promising new leprosy treatment option (less Side effects): 3-drug therapy only once a month for 12-24 months. This makes more sense. Credits to Dr Carlos-Franco Paredes. #IDWeek2024

Great meeting with Peruvian team at IDWeek2024. Collaboration is key to success in clinical translational research (Emerging Tropical Diseases/Immunology/Global Health/Climate change). @IDWeekmtg @SPEIT_oficial @CasapiaMartin @AlexisHolguinR1 @LAPAHSTropical #IDWeek2024

Thanks for inviting me as panelist for Unforgettable Cases in Tropical Medicine at #IDWeek2024 - Paragonimus, histoplasmosis, paracoccidioidomycosis, leprosy, dengue, leptospirosis, brucella, etc Dr Martin Casapia leads an amazing Tropical Medicine Course in the Amazon of Peru!

Big congrats to our fellows and residents in their posters presentations at IDWeek 2024!

A seven-day course of antibiotics for hospitalized patients with bloodstream infections is just as effective as a 14-day course, according to new findings presented at #IDWeek2024. Learn more: idsociety.org/news--publicat…

Sharing great moments with our Latin American brothers and planning new science in the Amazon ⁦@IDWeekmtg⁩ ⁦@SPEIT_oficial⁩ #TropMed ⁦@LuisAMarcosID⁩ ⁦@CUDivofID⁩ ⁦@StonyBrookID⁩ ⁦@rolosanchez77⁩

Our fantastic team at #IDWeek LA! @LuisAMarcosID and our fellows @IDWeekmtg 👏

Read our September issue! Featuring global burden of lower respiratory tract infections, testing a new regimen for treating tuberculosis, and a trial to optimize vaccination for Lyme disease. thelancet.com/journals/lanin…

HCPs: CDC issued a Health Alert Network (HAN) Health Advisory about an increase in #Oropouche virus disease reported in South America & the Caribbean. Five cases of vertical transmission associated with fetal death or congenital abnormalities have been reported. Read full advisory: bit.ly/3AoMOjg

I know first-hand how important Infectious Disease (ID) physicians are in a public health crisis. Yet, 80% of U.S. counties do not have an ID physician. To protect our nation’s public health, we must break down the barriers that stop medical students from becoming ID physicians.

【Daptomycin: Important to know】 Let's remember 5 important key points of daptomycin!! Level: Basic to intermediate Frequency: ★★★☆☆ #IDMedEd #IDFellow #IMResident #PharmD #BootCamp #Antimicrobials